HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 10-DEC-13 4NY9
TITLE CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH N-{(2R)-1-
TITLE 2 [(4S)-4-(4-CHLOROPHENYL)-4-HYDROXY-3,3-DIMETHYLPIPERIDIN-1-YL]-3-
TITLE 3 METHYL-1-OXOBUTAN-2-YL}-3-HYDROXY-3-METHYLBUTANAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: UNP RESIDUES 142-431;
COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1, ORPHAN NUCLEAR RECEPTOR PXR,
COMPND 6 PREGNANE X RECEPTOR, STEROID AND XENOBIOTIC RECEPTOR, SXR;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NR1I2, PXR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCO7
KEYWDS PREGNANE X RECEPTOR, PXR, LIGAND BINDING DOMAIN, STEROID RECEPTOR
KEYWDS 2 COACTIVATOR-1; CCR1, CHEMOKINE RECEPTOR-1; NR, NUCLEAR RECEPTOR; AF,
KEYWDS 3 ACTIVATION FUNCTION; MDR1, MULTI-DRUG RESISTANCE GENE-1,
KEYWDS 4 TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.A.KHAN,D.M.CAMAC
REVDAT 4 28-FEB-24 4NY9 1 REMARK
REVDAT 3 22-NOV-17 4NY9 1 REMARK
REVDAT 2 10-DEC-14 4NY9 1 JRNL
REVDAT 1 27-AUG-14 4NY9 0
JRNL AUTH J.B.SANTELLA,D.S.GARDNER,J.V.DUNCIA,H.WU,M.DHAR,C.CAVALLARO,
JRNL AUTH 2 A.J.TEBBEN,P.H.CARTER,J.C.BARRISH,M.YARDE,S.W.BRICENO,
JRNL AUTH 3 M.E.CVIJIC,R.R.GRAFSTROM,R.LIU,S.R.PATEL,A.J.WATSON,G.YANG,
JRNL AUTH 4 A.V.ROSE,R.D.VICKERY,J.CACERES-CORTES,C.CAPORUSCIO,
JRNL AUTH 5 D.M.CAMAC,J.A.KHAN,Y.AN,W.R.FOSTER,P.DAVIES,J.HYNES
JRNL TITL DISCOVERY OF THE CCR1 ANTAGONIST, BMS-817399, FOR THE
JRNL TITL 2 TREATMENT OF RHEUMATOID ARTHRITIS.
JRNL REF J.MED.CHEM. V. 57 7550 2014
JRNL REFN ISSN 0022-2623
JRNL PMID 25101488
JRNL DOI 10.1021/JM5003167
REMARK 2
REMARK 2 RESOLUTION. 2.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.88
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 9443
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.232
REMARK 3 R VALUE (WORKING SET) : 0.228
REMARK 3 FREE R VALUE : 0.298
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800
REMARK 3 FREE R VALUE TEST SET COUNT : 450
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87
REMARK 3 REFLECTION IN BIN (WORKING SET) : 640
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.13
REMARK 3 BIN R VALUE (WORKING SET) : 0.2590
REMARK 3 BIN FREE R VALUE SET COUNT : 42
REMARK 3 BIN FREE R VALUE : 0.3190
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2127
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 36
REMARK 3 SOLVENT ATOMS : 15
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.06
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.01000
REMARK 3 B22 (A**2) : 0.01000
REMARK 3 B33 (A**2) : -0.02000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 1.811
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.418
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.322
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.481
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 4NY9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-14.
REMARK 100 THE DEPOSITION ID IS D_1000083806.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 21-MAR-08
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 7.8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 22-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9474
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 200 DATA REDUNDANCY : 6.600
REMARK 200 R MERGE (I) : 0.11500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.60
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M IMIDAZOLE, 8-10%(V/V)ISOPROPANOL.
REMARK 280 APO CRYSTAL WAS SOAKED WITH 5 MM COMPOUND AND CRYSTALS HARVESTED
REMARK 280 NEXT DAY USING 32% ETHYLENE GLYCOL AS CRYOPROTECTANT, PH 7.8,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.82550
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.88000
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.88000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.23825
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.88000
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.88000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.41275
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.88000
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.88000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.23825
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.88000
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.88000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.41275
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.82550
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1810 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 26290 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000
REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 42.82550
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 VAL A 177
REMARK 465 LEU A 178
REMARK 465 SER A 179
REMARK 465 SER A 180
REMARK 465 GLY A 181
REMARK 465 CYS A 182
REMARK 465 GLU A 183
REMARK 465 LEU A 184
REMARK 465 PRO A 185
REMARK 465 GLU A 186
REMARK 465 SER A 187
REMARK 465 LEU A 188
REMARK 465 GLN A 189
REMARK 465 ALA A 190
REMARK 465 PRO A 191
REMARK 465 SER A 192
REMARK 465 ARG A 193
REMARK 465 GLU A 194
REMARK 465 GLU A 195
REMARK 465 ALA A 196
REMARK 465 ALA A 197
REMARK 465 LYS A 198
REMARK 465 TRP A 199
REMARK 465 SER A 200
REMARK 465 ASP A 310
REMARK 465 THR A 311
REMARK 465 ALA A 312
REMARK 465 GLY A 313
REMARK 465 GLY A 314
REMARK 465 PHE A 315
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OD2 ASP A 163 O HOH A 612 2.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 203 6.58 -164.48
REMARK 500 LYS A 234 -25.30 140.50
REMARK 500 CYS A 301 70.72 -102.98
REMARK 500 GLN A 317 87.13 58.05
REMARK 500 ASP A 352 64.93 -101.23
REMARK 500 PRO A 354 120.52 -23.21
REMARK 500 PRO A 384 -2.16 -57.05
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Q4 A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 502
DBREF 4NY9 A 142 431 UNP O75469 NR1I2_HUMAN 142 431
SEQRES 1 A 290 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU
SEQRES 2 A 290 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER
SEQRES 3 A 290 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER
SEQRES 4 A 290 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG
SEQRES 5 A 290 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU
SEQRES 6 A 290 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP
SEQRES 7 A 290 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY
SEQRES 8 A 290 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP
SEQRES 9 A 290 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA
SEQRES 10 A 290 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP
SEQRES 11 A 290 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS
SEQRES 12 A 290 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY
SEQRES 13 A 290 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP
SEQRES 14 A 290 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET
SEQRES 15 A 290 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS
SEQRES 16 A 290 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE
SEQRES 17 A 290 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL
SEQRES 18 A 290 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER
SEQRES 19 A 290 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE
SEQRES 20 A 290 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG
SEQRES 21 A 290 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE
SEQRES 22 A 290 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU
SEQRES 23 A 290 LEU PHE GLY ILE
HET 2Q4 A 501 30
HET GOL A 502 6
HETNAM 2Q4 N-{(2R)-1-[(4S)-4-(4-CHLOROPHENYL)-4-HYDROXY-3,3-
HETNAM 2 2Q4 DIMETHYLPIPERIDIN-1-YL]-3-METHYL-1-OXOBUTAN-2-YL}-3-
HETNAM 3 2Q4 HYDROXY-3-METHYLBUTANAMIDE
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 2Q4 C23 H35 CL N2 O4
FORMUL 3 GOL C3 H8 O3
FORMUL 4 HOH *15(H2 O)
HELIX 1 1 THR A 144 PHE A 162 1 19
HELIX 2 2 ARG A 203 SER A 208 1 6
HELIX 3 3 LYS A 234 SER A 238 5 5
HELIX 4 4 LEU A 239 VAL A 260 1 22
HELIX 5 5 ILE A 261 ASP A 266 1 6
HELIX 6 6 PRO A 268 VAL A 291 1 24
HELIX 7 7 GLU A 321 LEU A 333 1 13
HELIX 8 8 HIS A 336 PHE A 349 1 14
HELIX 9 9 GLN A 358 ARG A 381 1 24
HELIX 10 10 PHE A 388 HIS A 418 1 31
HELIX 11 11 THR A 422 GLY A 430 1 9
SHEET 1 A 5 VAL A 222 TYR A 225 0
SHEET 2 A 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225
SHEET 3 A 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212
SHEET 4 A 5 THR A 298 CYS A 301 -1 N TRP A 299 O TYR A 306
SHEET 5 A 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298
SITE 1 AC1 9 VAL A 211 MET A 243 ALA A 244 GLN A 285
SITE 2 AC1 9 PHE A 288 TRP A 299 TYR A 306 HIS A 407
SITE 3 AC1 9 HOH A 605
SITE 1 AC2 7 THR A 161 PHE A 162 ASP A 163 TYR A 249
SITE 2 AC2 7 MET A 250 GLY A 253 ARG A 287
CRYST1 91.760 91.760 85.651 90.00 90.00 90.00 P 43 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010898 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010898 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011675 0.00000